News

Eli Lilly (LLY) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...
Efsitora matched or exceeded A1C reductions seen with daily basal insulin across three trials, while orforglipron ...
Eli Lilly and Company (NYSE: LLY) today announced detailed results from ACHIEVE-1, a Phase 3 trial evaluating the safety and efficacy of orforglipron compared to placebo in adults with type 2 ...
New data from a Phase 3 trial show that the daily anti-obesity pill may be as safe and effective as drugs like Mounjaro and ...
Providing a diverse range of perspectives from bullish to bearish, 7 analysts have published ratings on Eli Lilly LLY -1.05% ...
Eli Lilly and Company (NYSE:LLY) may offer a modest dividend yield, but its track record of consistent payouts remains strong ...
Healthcare & Pharmaceuticalscategory· June 17, 2025 Eli Lilly to acquire gene-editing ... Denmark's Novo Nordisk is partnering with biotech company Deep Apple Therapeutics in a deal worth up ...
Companies are always in the race for the top spot, and the only way to achieve it is by reaching a high market valuation. The ...